Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel With or Without Sunitinib in Advanced Solid Tumors
NCT01803503Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- May 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in solid tumor, breast cancer, non-small cell lung cancer (NSCLC), prostate cancer (PCa), gastric cancer (GC), sponsored by National University Hospital. Status: unknown.
02
Drugs
sunitinib
03
Conditions
solid tumorbreast cancernon-small cell lung cancer (NSCLC)prostate cancer (PCa)gastric cancer (GC)
Beyond the preview
Go deeper on NCT01803503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01803503.